Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. DNTH has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
DNTH stock price ended at $19.24 on Monday, after losing-2.29%
The Dianthus Therapeutics Inc stock price decreased by -2.29% on the last trading day (19 May 2025), dropping from 19.99 to 19.24. Throughout the last trading session, the stock experienced a fluctuation of 4.82% , ranging from a day low of $19.07 to a day high of 19.99. The price has declined in 5 of the last 10 days, resulting in a total change of -10.72% during this period. On the last day, trading volume increase by -91.06K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 247.72K shares were traded, amounting to approximately 4.79M.
DNTH Technical Signals
DNTH(Dianthus Therapeutics Inc Corp) has 1 buy signal and 3 sell signals now. The current trend is consolidation starting from 2025-05-15. The total price change during this trend is +2.61%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of DNTH over the last 5 trading days is 5.58M. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
DNTH Moving Average Analysis
Dianthus Therapeutics Inc's overall moving average trend leans more bearish as of Tuesday, May 20, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $21.786763333333333, and $22.984333333333332. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $17.911903333333335, and $16.714333333333336. A break-down below any of these levels will issue sell signals.
DNTH Short Selling Analysis
The short sale ratio of Dianthus Therapeutics Inc(DNTH) as of 12 May 2025 is 24.44%, dropping from last trading day. With decreasing price from 19.59 to 20.08. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
3
Buy
1
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
1 Bullish Signals
1 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
18.289
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.00969
Bearish
Momentum (10 days)
MOM_10 < 0
-2.31
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.167
Bearish
DNTH Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Dianthus Therapeutics Inc(DNTH), our algorithm predicts DNTH's 1-month price at $19.46, with an -1.16%downwardshift. Using a similarity score up to 97.60%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Dianthus Therapeutics Inc (DNTH.O) stock, as of Sunday, May 18, 2025 , forecasts a -1.16% change over the next month, based on its high correlation with KT.N stock patterns. The similarity between their price movements over the analyzed periods is 97.6%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
DNTH
No Data
KT
Down: -1.16%Similarity: 97.6%
Name
Similarity
Up/Down
KT.N
97.60%
-1.16%
ECL.N
97.30%
+1.47%
MLM.N
97.25%
-2.70%
JEF.N
97.21%
+6.41%
ENTG.O
97.16%
+10.12%
HD.N
96.98%
+0.60%
FNF.N
96.95%
+0.03%
SEDG.O
96.76%
+2.16%
ULBI.O
96.69%
+13.90%
SILC.O
96.66%
+4.01%
DNTH Seasonality Analysis
Based on DNTH's historical stock price data across all years, the probability of a positive return in May is57.14%, suggesting it maybe an ideal month to invest in DNTH. In contrast,Januaryoffers the highest probability of positive returns at71.43%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Dianthus Therapeutics Inc (DNTH.O) stock in January has the highest probability of a positive return (71.43%), while April has the lowest probability (28.57%).
Performance Seasonality
The chart shows Dianthus Therapeutics Inc. (DNTH)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Dianthus Therapeutics Inc (DNTH.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. DNTH has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Dianthus Therapeutics Inc (DNTH.O) stock in a year?
The radar chart shows that buying Dianthus Therapeutics Inc (DNTH.O) stock in January has the highest probability of a positive return (71.43%), while April has the lowest probability (28.57%).
How has Dianthus Therapeutics Inc. (DNTH)'s stock price performed over the past three years?
DNTH's stock price rose by 2436.59% in 2023,increased by 90.39% in 2024, and went down by 17.07% in 2025.
Which bull technical signals does DNTH have?
Bullish technical signals of DNTH include: STOCHRSIk_14_14_3_3 < 20.
Is DNTH a buy based on overall technical signals summary?
DNTH has 1 buy signals and 3 sell signals now. Overall the technical rating for DNTH is Sell . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of DNTH.
What is the trend of Dianthus Therapeutics Inc (DNTH)'s moving average?
Dianthus Therapeutics Inc's overall moving average trend leans more bearish as of May 20 2025, with 2 negative signals and 2 positive signal.
What is price prediction for DNTH stock next month?
The price prediction chart for Dianthus Therapeutics Inc (DNTH.O) stock, as of May 18 2025, forecasts a -1.16% change over the next month, based on its high correlation with KT stock patterns. The similarity between their price movements over the analyzed periods is 97.6%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for DNTH Stock?
Based on the analysis of DNTH stock, the price prediction for 2025 is $28 with a potential upside to $35. The stock is currently near key support levels and shows signs of potential bullish momentum, supported by analyst targets.
What is price prediction 2030 for DNTH Stock?
Dianthus Therapeutics (DNTH) is projected to reach **$35 by 2030**, driven by strong clinical trial progress and increasing investor optimism. The stock could potentially reach **$50 if its Phase 2 and Phase 3 trials succeed**, leveraging its pipeline in neuromuscular diseases. Current options activity and positive trial data position DNTH for significant growth.